Heart Failure and Cardiomyopathies
COMPARATIVE EFFECTIVENESS AND SAFETY OF EMPAGLIFLOZIN: AN INTERIM ANALYSIS FROM THE EMPAGLIFLOZIN COMPARATIVE EFFECTIVENESS AND SAFETY (EMPRISE) STUDY

https://doi.org/10.1016/S0735-1097(19)31291-4Get rights and content
Under an Elsevier user license
open archive

Cited by (0)

Moderated Poster Contributions

Heart Failure and Cardiomyopathies Moderated Poster Theater, Poster Hall, Hall F

Sunday, March 17, 2019, 3:45 p.m.-3:55 p.m.

Session Title: The Role of SGLT2 inhibitors in Heart Failure

Abstract Category: 14. Heart Failure and Cardiomyopathies: Therapy

Presentation Number: 1038-03

Copyright © 2019 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.